CLARITI (TM) 1-Day Multifocal Contact Lenses Performance and Acceptance Evaluation

NCT02147093 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

A comparative evaluation of a newly marketed multifocal contact lens with a single vision contact lens when used with near vision spectacles. The evaluation was to quantify the difference between the two test corrections.

Conditions

  • Presbyopia Correction

Interventions

DEVICE

Test (multi-focal)

contact lens was to be worn a daily wear.

DEVICE

Control (Sphere)

contact lens was to be worn a daily wear with spectacles

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-01
Primary Completion
2014-08-01
Completion
2014-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02147093 on ClinicalTrials.gov